NOVN.SW vs. SPGI

Last updated Jun 13, 2026

NOVN.SW (Novartis AG) and SPGI (S&P Global Inc.) are both stocks. NOVN.SW operates in Drug Manufacturers - General (Healthcare), while SPGI operates in Financial Data & Stock Exchanges (Financial Services). Over the past 10 years, NOVN.SW returned 12.72%/yr vs 13.52%/yr for SPGI. At a 0.26 correlation, their price movements are largely independent.

Performance

NOVN.SW vs. SPGI - Performance Comparison

The chart below illustrates the hypothetical performance of a CHF 10,000 investment in Novartis AG (NOVN.SW) and S&P Global Inc. (SPGI). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

NOVN.SW is traded in CHF, while SPGI is traded in USD. To make them comparable, the SPGI values have been converted to CHF using the latest available exchange rates.

Returns By Period

In the year-to-date period, NOVN.SW achieves a 14.78% return, which is significantly higher than SPGI's -19.13% return. Over the past 10 years, NOVN.SW has underperformed SPGI with an annualized return of 12.72%, while SPGI has yielded a comparatively higher 13.52% annualized return.

NOVN.SW

• 1D: 0.44%
• 1M: 4.52%
• YTD: 14.78%
• 6M: 19.24%
• 1Y: 28.27%
• 3Y*: 21.71%
• 5Y*: 16.36%
• 10Y*: 12.72%

SPGI

• 1D: 1.55%
• 1M: 5.22%
• YTD: -19.13%
• 6M: -15.91%
• 1Y: -17.90%
• 3Y*: -1.11%
• 5Y*: -0.26%
• 10Y*: 13.52%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NOVN.SW vs. SPGI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NOVN.SW Novartis AG	14.78%	27.98%	8.44%	28.10%	8.50%	-0.33%	-5.58%	28.24%	6.26%	15.78%
SPGI S&P Global Inc.	-19.13%	-7.64%	22.92%	20.91%	-27.40%	48.95%	11.16%	59.51%	2.36%	52.55%

Correlation

The correlation between NOVN.SW and SPGI is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.03
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (10Y) Calculated over the trailing 10-year period	0.23
Correlation (All Time) Calculated using the full available price history since Sep 6, 2007	0.26

Over the past year, the correlation between NOVN.SW and SPGI has dropped to 0.03 - well below their long-term average of 0.26, suggesting their price drivers have been diverging.

Return for Risk

NOVN.SW vs. SPGI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NOVN.SW

NOVN.SW Risk / Return Rank: 80
NOVN.SW Sharpe Ratio Rank: 84
NOVN.SW Sortino Ratio Rank: 78
NOVN.SW Omega Ratio Rank: 78
NOVN.SW Calmar Ratio Rank: 82
NOVN.SW Martin Ratio Rank: 81

SPGI

SPGI Risk / Return Rank: 19
SPGI Sharpe Ratio Rank: 17
SPGI Sortino Ratio Rank: 18
SPGI Omega Ratio Rank: 17
SPGI Calmar Ratio Rank: 24
SPGI Martin Ratio Rank: 22

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NOVN.SW vs. SPGI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NOVN.SW) and S&P Global Inc. (SPGI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NOVN.SW	SPGI	Difference
Sharpe ratio: Return per unit of total volatility	1.54	-0.63	+2.17
Sortino ratio: Return per unit of downside risk	2.05	-0.67	+2.72
Omega ratio: Gain probability vs. loss probability	1.27	0.90	+0.37
Calmar ratio: Return relative to maximum drawdown	2.66	-0.53	+3.19
Martin ratio: Return relative to average drawdown	6.32	-1.02	+7.34

NOVN.SW vs. SPGI - Sharpe Ratio Comparison

The current NOVN.SW Sharpe Ratio is 1.54, which is higher than the SPGI Sharpe Ratio of -0.63. The chart below compares the historical Sharpe Ratios of NOVN.SW and SPGI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

NOVN.SW vs. SPGI - Drawdown Comparison

The maximum NOVN.SW drawdown since its inception was -42.59%, smaller than the maximum SPGI drawdown of -67.41%. Use the drawdown chart below to compare losses from any high point for NOVN.SW and SPGI.

Drawdown Indicators

	NOVN.SW	SPGI	Difference
Max Drawdown Largest peak-to-trough decline	-42.59%	-67.41%	+24.82%
Max Drawdown (1Y) Largest decline over 1 year	-10.78%	-33.64%	+22.86%
Max Drawdown (3Y) Largest decline over 3 years	-16.86%	-38.54%	+21.68%
Max Drawdown (5Y) Largest decline over 5 years	-16.86%	-38.54%	+21.68%
Max Drawdown (10Y) Largest decline over 10 years	-24.26%	-38.82%	+14.56%
Current Drawdown Current decline from peak	-3.61%	-31.58%	+27.97%
Average Drawdown Average peak-to-trough decline	-11.45%	-17.01%	+5.56%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.53%	17.57%	-13.04%

Volatility

NOVN.SW vs. SPGI - Volatility Comparison

The current volatility for Novartis AG (NOVN.SW) is 5.72%, while S&P Global Inc. (SPGI) has a volatility of 7.59%. This indicates that NOVN.SW experiences smaller price fluctuations and is considered to be less risky than SPGI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NOVN.SW	SPGI	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.72%	7.59%	-1.87%
Volatility (6M) Calculated over the trailing 6-month period	13.24%	25.06%	-11.82%
Volatility (1Y) Calculated over the trailing 1-year period	18.68%	28.46%	-9.78%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.91%	24.74%	-5.83%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.77%	26.83%	-8.06%

Dividends

NOVN.SW vs. SPGI - Dividend Comparison

NOVN.SW's dividend yield for the trailing twelve months is around 3.03%, more than SPGI's 0.92% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NOVN.SW Novartis AG	3.03%	3.19%	3.72%	3.77%	3.71%	3.74%	3.53%	3.10%	3.77%	3.78%	4.12%	3.39%
SPGI S&P Global Inc.	0.92%	0.73%	0.73%	0.82%	0.99%	0.65%	0.82%	0.84%	1.18%	0.97%	1.34%	1.34%

Financials

Frequently Asked Questions

Can I hold both NOVN.SW and SPGI in my portfolio?

NOVN.SW and SPGI have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.